Related Experiment Video
Updated: Jul 14, 2026
12:33
A Method for Mouse Pancreatic Islet Isolation and Intracellular cAMP Determination
Published on: June 25, 2014
Type 1 diabetic serum interferes with pancreatic beta-cell Ca2+-handling
N Dekki1, R Nilsson, S Norgren
1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, L1, Stockholm, 171 76, Sweden.
Bioscience Reports
|June 29, 2007
Summary
Approximately 30% of type 1 diabetes patients and their relatives have serum that impairs pancreatic beta-cell calcium handling. This serum effect on calcium (Ca2+) does not correlate with autoantibodies but may worsen beta-cell destruction.
Area of Science:
- Endocrinology
- Cell Biology
- Immunology
Background:
- Type 1 diabetes involves autoimmune destruction of pancreatic beta-cells.
- Serum factors may influence beta-cell function and survival.
- Calcium homeostasis is critical for beta-cell function.
Purpose of the Study:
- To determine the frequency of serum-induced increases in pancreatic beta-cell cytoplasmic free Ca(2+) ([Ca(2+)](i)) in type 1 diabetes patients.
- To investigate if this serum effect is present in first-degree relatives of type 1 diabetes patients.
- To explore potential links between the serum effect, ethnic background, and autoantibody presence.
Main Methods:
- Sera from type 1 diabetes patients and first-degree relatives across different countries were collected.
- Beta-cells were incubated with sera, and changes in [Ca(2+)](i) upon depolarization were measured.
- Statistical analysis was performed to correlate the serum effect with patient demographics and autoantibody status.
Main Results:
- A subset of approximately 30% of type 1 diabetes patients and first-degree relatives exhibited sera that interfered with pancreatic beta-cell Ca(2+)-handling.
- This serum effect was observed across diverse genders, ages, ethnic backgrounds, and disease durations.
- No correlation was found between the observed serum effect and the presence of autoantibodies.
Conclusions:
- A significant proportion of individuals with type 1 diabetes and their first-degree relatives possess serum factors that disrupt beta-cell calcium regulation.
- This impaired calcium handling in beta-cells, potentially mediated by serum factors, may contribute to the progressive destruction of these cells in type 1 diabetes.
- Further research is warranted to elucidate the specific serum factors involved and their precise role in type 1 diabetes pathogenesis.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...